Skip to main navigation Skip to search Skip to main content

A phase 3 randomized double-blind trial of maintenance with niraparib versus placebo in patients with platinum-sensitive ovarian cancer (ENGOT-OV16/NOVA trial)

  • Ursula Matulonis
  • , Sven Mahner
  • , Robert Michael Wenham
  • , Jonathan A. Ledermann
  • , Bradley J. Monk
  • , Jose Maria Del Campo
  • , Jonathan S. Berek
  • , Ignace Vergote
  • , Michel Fabbro
  • , Dionyssios Katsaros
  • , Christian Marth
  • , Domenica Lorusso
  • , Jørn Herrstedt
  • , Shefali Agarwal
  • , Robert E. Martell
  • , Mansoor Raza Mirza
  • Rigshospitalet
  • University Hospitals Leuven

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

Original languageEnglish
Publication date2014
Publication statusPublished - 2014
Event50th Annual Meeting of American Society of Clinical Oncology: Science & Society - Chicago, Illinois, United States
Duration: 30. May 2014 → 3. Jun 2014
Conference number: 50

Conference

Conference50th Annual Meeting of American Society of Clinical Oncology
Number50
Country/TerritoryUnited States
CityChicago, Illinois
Period30/05/2014 → 03/06/2014

Bibliographical note

Abstract number TPS5625

Cite this